Ann: IHL-42X phase 2 clinical trial presentation, page-27

The results are excellent and better than we could have hoped for . Stunning benefit at low dose , no negative effects . We are on our way here . This is where the real increments will come as we move to the next phase and toward commercialisation . Users would much rather take a than have a machine strapped to their face i am sure and the sleep industry would want to get on board here . Only a matter of time in my view . Patience .

I recall owning two major Aussie biotech companies that I sold early two decades ago thinking I was doing the right thing only to regret the move decades later . We may just be on one such stock here that has the potential to be a life changer . I am holding as it is being de risked significantly with each passing month in my opinion . So I will hold and go for the ride .